Ilan Shimon Selected Research

pasireotide

10/2022	Pituitary acting drugs: cabergoline and pasireotide.
11/2021	Long-term safety and efficacy of long-acting pasireotide in acromegaly.
12/2020	Risk factors and management of pasireotide-associated hyperglycemia in acromegaly.
11/2020	Medical Treatment Landscape for Active Acromegaly in A Pituitary Center in Israel.
6/2020	MEDICAL TREATMENT LANDSCAPE FOR ACTIVE ACROMEGALY IN A PITUITARY CENTER IN ISRAEL.
6/2020	Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study.
2/2020	Prolactinomas in males: any differences?
3/2019	PASIREOTIDE FOR A PATIENT WITH ACROMEGALY AND CHRONIC KIDNEY DISEASE ON HEMODIALYSIS.
11/2018	Efficacy and safety of long-acting pasireotide in patients with somatostatin-resistant acromegaly: a multicenter study.
1/2017	Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilan Shimon Research Topics

Disease

39	Neoplasms (Cancer) 10/2022 - 01/2002
20	Adenoma (Adenomas) 01/2022 - 07/2002
19	Acromegaly 01/2022 - 01/2009
17	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 07/2002
13	Prolactinoma (Prolactinomas) 10/2021 - 01/2004
10	Diabetes Mellitus 11/2021 - 01/2016
9	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2004
6	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2020 - 12/2005
6	Neoplasm Metastasis (Metastasis) 05/2019 - 06/2007
5	Hypopituitarism (Sheehan's Syndrome) 06/2019 - 10/2012
4	Cushing Syndrome 10/2022 - 01/2011
4	Pituitary ACTH Hypersecretion 12/2021 - 01/2006
4	Osteoporosis 12/2020 - 12/2005
4	Papillary Thyroid Cancer 05/2019 - 11/2014
4	Hypoglycemia (Reactive Hypoglycemia) 01/2019 - 01/2017
4	Hypothyroidism 05/2017 - 09/2002
3	Hyperglycemia 10/2022 - 05/2005
3	Cholelithiasis 11/2020 - 11/2018
3	Hypercalciuria 05/2020 - 01/2017
3	Lymphatic Metastasis 01/2020 - 05/2019
3	Hyperprolactinemia 08/2018 - 11/2015
3	Pituitary Diseases (Disease, Anterior Pituitary) 08/2016 - 05/2006
3	Body Weight (Weight, Body) 03/2012 - 02/2006
2	Hypocalcemia 12/2020 - 08/2017
2	Hypertension (High Blood Pressure) 12/2020 - 01/2016
2	Anemia 02/2020 - 03/2011
2	Rare Diseases (Rare Disease) 06/2019 - 04/2015
2	Graves Ophthalmopathy 01/2019 - 10/2014
2	Headache (Headaches) 11/2018 - 10/2012
2	Hypercalcemia (Milk Alkali Syndrome) 08/2017 - 01/2017
2	Hyperparathyroidism 04/2017 - 08/2013
2	Diabetes Insipidus 08/2016 - 04/2016
2	Hyperthyroidism 04/2016 - 01/2007
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2012 - 02/2010
2	Carcinoid Tumor (Carcinoid) 10/2008 - 01/2004
2	Infections 02/2003 - 01/2002
1	Mental Disorders (Mental Disorder) 10/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2022
1	Acidosis 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021
1	Dyslipidemias (Dyslipidemia) 12/2020

Drug/Important Bio-Agent (IBA)

16	ProlactinIBA 01/2022 - 04/2003
14	pasireotideIBA 10/2022 - 12/2012
14	Growth Hormone (Somatotropin)IBA 01/2022 - 04/2003
14	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2019 - 04/2003
10	Dopamine Agonists (Dopamine Agonist)IBA 01/2022 - 01/2004
9	Cabergoline FDA LinkGeneric 10/2022 - 02/2007
9	Octreotide (Sandostatin)FDA LinkGeneric 11/2021 - 04/2003
9	Insulin-Like Growth Factor I (IGF-1)IBA 11/2021 - 01/2002
8	GlucocorticoidsIBA 03/2022 - 01/2006
8	Thyroglobulin FDA Link 01/2020 - 10/2010
7	lanreotide (Somatuline)FDA Link 11/2021 - 01/2009
7	Testosterone (Sustanon)FDA Link 02/2020 - 12/2005
7	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020 - 09/2002
7	Hormones (Hormone)IBA 11/2019 - 04/2003
6	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2022 - 07/2002
6	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2022 - 12/2012
6	Insulin (Novolin)FDA Link 03/2021 - 01/2002
6	IodineIBA 05/2019 - 10/2014
6	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2016
5	Insulin-Like PeptidesIBA 11/2021 - 01/2002
5	Glucose (Dextrose)FDA LinkGeneric 03/2021 - 07/2016
4	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019 - 09/2002
3	AlbuminsIBA 12/2020 - 08/2017
3	Pharmaceutical PreparationsIBA 12/2020 - 01/2016
3	AntibodiesIBA 01/2020 - 06/2013
3	Bromocriptine (Parlodel)FDA LinkGeneric 01/2019 - 01/2004
3	Biomarkers (Surrogate Marker)IBA 08/2016 - 11/2015
3	Proteins (Proteins, Gene)FDA Link 07/2016 - 02/2010
3	Everolimus FDA Link 01/2016 - 09/2009
2	CalciumIBA 12/2020 - 08/2017
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2019 - 02/2003
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2018 - 04/2016
2	LigandsIBA 11/2018 - 12/2012
2	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2018 - 12/2012
2	amsonic acid (DAS)IBA 09/2016 - 01/2015
2	Proton Pump InhibitorsIBA 07/2016 - 04/2011
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2016 - 06/2007
2	MTOR InhibitorsIBA 01/2016 - 09/2009
2	GonadotropinsIBA 12/2014 - 05/2006
2	Pituitary HormonesIBA 12/2014 - 05/2006
2	LeptinIBA 03/2012 - 02/2006
2	Messenger RNA (mRNA)IBA 12/2011 - 08/2003
2	GastrinsIBA 04/2011 - 10/2008
2	Sirolimus (Rapamycin)FDA Link 02/2010 - 09/2009
2	GhrelinIBA 06/2006 - 02/2006
2	Thyroid HormonesIBA 02/2003 - 09/2002
1	KetonesIBA 01/2021
1	CreatinineIBA 12/2020
1	Denosumab FDA Link 12/2020

Therapy/Procedure

20	Therapeutics 10/2022 - 01/2006
8	Radiotherapy 10/2022 - 01/2004
5	Thyroidectomy 01/2020 - 11/2014
3	Adrenalectomy 12/2018 - 01/2006
2	Length of Stay 01/2019 - 01/2018
2	Glycemic Control 10/2018 - 04/2016
2	Contraindications 09/2016 - 01/2015
2	Aftercare (After-Treatment) 02/2015 - 02/2014
1	Procedure Contraindications 10/2022
1	Parathyroidectomy 05/2020